Japan research supports use of Ivermectin

 PJ Media:

Anti-parasite drug Ivermectin shows an “antiviral effect” against omicron and other COVID variants according to research released Monday by Japanese pharmaceutical giant Kowa.

According to Reuters, the firm has been working with Tokyo’s Kitasato University.

While Reuters described the study as “non-clinical,” last June the American Journal of Therapeutics published a meta-analysis of 15 different clinical studies.

That AJT analysis concluded:

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

The next month, podcast star Joe Rogan took Ivermectin to treat himself for COVID with well-known positive results — something NBC News at the time called a “widely discredited drug.”

That same AJT analysis remarked that “Ivermectin has exhibited antiviral activity against a wide range of RNA and some DNA viruses,” which would seem to be in line with today’s news out of Japan.

...

This could explain why families are sneaking it into patients who are near death.  It is apparently most effective in the early treatment of the virus.  I noticed that Facebook has in the past indicated that this off use could be dangerous without indicating what the effects were.

See, also:

146 Research Studies Affirm Naturally Acquired Immunity to COVID-19

Comments

Popular posts from this blog

Should Republicans go ahead and add Supreme Court Justices to head off Democrats

29 % of companies say they are unlikely to keep insurance after Obamacare

Bin Laden's concern about Zarqawi's remains